A collaborative study with Harvard Medical School
A Clinical Case Series: Evaluation of a Bioactive Microfibre Gelling (BMG™) Dressing to Support Improved Service Delivery in Chronic Wound Management
Publication Details:
Tickle, J., A clinical case series: Evaluation of a Bioactive Microfibre Gelling (BMG™) dressing to support improved service delivery in the management of chronic wounds in a wound healing clinic. St. Mary's Hospital, Isle of Wight, 2023
Wound Details
Patient Pool: 11 patients with chronic, non-healing wounds of various aetiologies
Key Findings and Data:
- Initial wound state: >75% necrotic/sloughy tissue
- Week 4: Reduced to 17% necrotic/sloughy tissue
- Granulation & epithelialization tissue increased from 20% at baseline to 80% at week 4
- 6 out of 11 wounds: “Complete” or “Almost healed”
- Remaining 5 patients: Wounds classified as “healing”
- Initial Pain Score: 5.8 ± 2.7
- Week 3 Pain Score: 2.5 ± 1.9
Key Insights
MaxioCel® demonstrated remarkable efficacy in managing chronic wounds, delivering:
- Rapid transition from sloughy to granulating tissue
- Superior exudate management & skin protection
- Significant pain reduction
High clinician & patient satisfaction
Related Publications
Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers
Chronic Wound Debridement in an Acute Setting
Severe Pressure Ulcer Debridement in the Acute Sector
A Multi-disciplinary Team Approach to the Management
